HER2 Nanoparticle Safety and Specificity Data Presented at AACR 2019

Marie Zhang, PhD, Vice President of Research and Clinical Development at Imagion Biosystems, presented the poster "HER2 Functionalized Nanoparticles Are Safe…


What's New in Medical Imaging — Radio Interview with Mike Harsh

Click play icon ▶️ to listen (transcript follows below):…


MagSense™ Pre-Clinical Study Presented at 2018 SABCS

On Saturday, December 8, 2018, Marie Zhang, PhD presented the poster "Detection of HER2 Positive Tumor Cells Using Functionalized Iron Oxide Nanoparticles" at…


MagSense™ Technology at ASCO 2018 Annual Meeting

The ASCO 2018 Annual Meeting abstract, "Detection and measurement of HER2+ breast cancer cells using tumor-targeted iron oxide nanoparticles and magnetic…


Introduction to Magnetic Relaxometry

This video (below) captures the opening minutes of CEO Bob Proulx's address to the 2016 NobleCon meeting, where he outlines the medical need for a new cancer…


Appendix 4C for Q2 2017

In accord with ASX requirements, Imagion Biosystems' quarterly financial statement Appendix 4C was lodged with the Australian Securities Exchange on 31 July,…


Hear Bob Proulx Interviewed by Health Professional Radio

Imagion Biosystems President and CEO Bob Proulx was interviewed today by Health Professional Radio, a media network dedicated to promoting awareness on…


Pre-IPO Investor Conference Call

On June 20, 2017, Imagion Biosystems President and CEO Bob Proulx provided an update and briefing on the pending Imagion Biosystems initial public offering on…


Magnetic Relaxometry at AACR 2017

This year's Annual Meeting of the American Association for Cancer Research was held April 1-5 in Washington, D.C. The theme of this year's meeting was…


Detecting Small Tumors

Cancerous tumors start small and grow larger over time, adding defensive mechanisms that make them resistant to treatments and more deadly. So, to find cancers…